
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.39 | -7.0594210259 | 19.69 | 20.005 | 17.15 | 1608436 | 18.76513351 | CS |
4 | -5.77 | -23.9717490652 | 24.07 | 25.29 | 17.15 | 2008725 | 21.62860786 | CS |
12 | 0.95 | 5.47550432277 | 17.35 | 25.29 | 16.588 | 1570815 | 20.24808753 | CS |
26 | 5.62 | 44.3217665615 | 12.68 | 25.29 | 11.89 | 1654034 | 18.13448014 | CS |
52 | 9.71 | 113.038416764 | 8.59 | 25.29 | 5.12 | 1435393 | 13.73911464 | CS |
156 | -7.49 | -29.0422644436 | 25.79 | 30.35 | 5.12 | 1262495 | 15.33946364 | CS |
260 | -6.85 | -27.2365805169 | 25.15 | 33.0899 | 5.12 | 1104751 | 16.839914 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales